Vitrolife AB 

$11
6
+$0+0% Monday 20:00

Statistics

Day High
11
Day Low
11
52W High
18.55
52W Low
9.5
Volume
130
Avg. Volume
256
Mkt Cap
1.49B
P/E Ratio
53
Dividend Yield
1.12%
Dividend
0.12

Upcoming

Dividends

1.12%Dividend Yield
May 25
$0.11
May 24
$0.09
May 23
$0.08
May 22
$0.08
May 21
$0.09
10Y Growth
N/A
5Y Growth
5.55%
3Y Growth
13.96%
1Y Growth
8.16%

Earnings

23AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-11.88
-7.54
-3.2
1.13
Expected EPS
0.8103869268
Actual EPS
N/A

Financials

14.21%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
654.9MRevenue
93.08MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VTRLY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Traeger
COOK
Mkt Cap125.02M
Cooper Companies operates in the fertility and women's health care sector, directly competing with Vitrolife in the IVF product market.
ICU Medical
ICUI
Mkt Cap3.03B
ICU Medical provides medical devices used in IVF clinics, overlapping with Vitrolife's offerings in assisted reproductive technology.
Hologic
HOLX
Mkt Cap16.45B
Hologic offers diagnostic products and medical devices for women's health, including technologies used in reproductive applications.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers medical technologies and services that are used in various healthcare settings, including reproductive health, competing with Vitrolife's medical devices.
Baxter International
BAX
Mkt Cap9.49B
Baxter International manufactures medical devices and instruments that are used in hospital and clinical settings, including those for reproductive health.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific provides various laboratory equipment and consumables used in life sciences and IVF clinics, competing with Vitrolife's lab products.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation produces biomedical testing and diagnostic instruments that are used in IVF and reproductive health, similar to Vitrolife's offerings.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company manufactures medical supplies and devices, including those for reproductive health applications, competing with Vitrolife.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation offers medical devices that are used in various health applications, including reproductive procedures.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical develops robotic-assisted surgical systems, which are increasingly used in reproductive surgeries, indirectly competing with Vitrolife's manual IVF technologies.

About

Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.
Show more...
CEO
Ms. Bronwyn Brophy O´Connor
Employees
1150
Country
SE
ISIN
US92852Y1010

Listings

0 Comments

Share your thoughts

FAQ

What is Vitrolife AB stock price today?
The current price of VTRLY is $11 USD — it has increased by +0% in the past 24 hours. Watch Vitrolife AB stock price performance more closely on the chart.
What is Vitrolife AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vitrolife AB stocks are traded under the ticker VTRLY.
What is Vitrolife AB market cap?
Today Vitrolife AB has the market capitalization of 1.49B
When is the next Vitrolife AB earnings date?
Vitrolife AB is going to release the next earnings report on April 23, 2026.
What were Vitrolife AB earnings last quarter?
VTRLY earnings for the last quarter are 0.07 USD per share, whereas the estimation was -1.34 USD resulting in a +105.35% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Vitrolife AB revenue for the last year?
Vitrolife AB revenue for the last year amounts to 654.9M USD.
What is Vitrolife AB net income for the last year?
VTRLY net income for the last year is 93.08M USD.
Does Vitrolife AB pay dividends?
Yes, VTRLY dividends are paid annual. The last dividend per share was 0.11 USD. As of today, Dividend Yield (FWD)% is 1.12%.
How many employees does Vitrolife AB have?
As of March 18, 2026, the company has 1,150 employees.
In which sector is Vitrolife AB located?
Vitrolife AB operates in the Health Care sector.
When did Vitrolife AB complete a stock split?
The last stock split for Vitrolife AB was on June 01, 2018 with a ratio of 1.25:1.
Where is Vitrolife AB headquartered?
Vitrolife AB is headquartered in Gothenburg, SE.